Navigation Links
UAB Cancer Center, urologists affirm men should take lead in deciding prostate screening

BIRMINGHAM, Ala. Men who undergo prostate-cancer screening should discuss with a doctor the uncertainties, risks and benefits of the test before it is performed, says Edward Partridge, M.D., president-elect of the American Cancer Society (ACS) National Board of Directors and director of the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center.

"We reaffirm the importance of informed and shared decision-making between a man and his doctor regarding prostate screening," Partridge says. "We want people talking openly and honestly with a health-care provider about the pros and cons of these tests to be in a better position to understand the results."

His comments came after the ACS issued updated screening guidelines that suggest doctors more actively involve patients in the decision of whether or not to be screened for prostate cancer. While not a radical change from the previous prostate-screening recommendations, the new guidelines offer clearer guidance on those things that should be discussed, says Partridge, a co-investigator on the national Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO trial) that helped inform the updated guidelines.

Erik Busby, M.D., an assistant professor in the UAB Division of Urology, seconded Partridge. "The bottom line is that physicians need to inform men of the benefits of screening before performing it, and the decision should be made with a trusted source of regular care," Busby says. "Men without access to regular care should be offered high-caliber screening counseling, and they should get appropriate follow-up care."

Prostate cancer is the most common non-skin cancer found in American men. When it is detected early, prostate cancer often can be treated successfully; more than 2 million U.S. men who have been diagnosed with prostate cancer are alive today, Busby says.

The new guidelines provide detailed advice on the kind of information that should be discussed regarding the pros and cons of the screening tests, including the prostate-specific antigen (PSA) blood test and a digital rectal exam. The guideline's authors recommend an honest discussion of these issues and point out the need to distribute educational materials, including brochures or a video, to better explain uncertainties, risks and benefits of the tests.

The ACS recommends that men age 50 with no symptoms of prostate cancer who are in relatively good health should be active in making an informed decision with their physician about prostate screening.

Men at high risk African-Americans and men with a father, brother or son diagnosed with prostate cancer before age 65 should begin that informed-decision talk earlier, at age 45. Those at higher risk, such as men with multiple family members affected by the disease before age 65, should start talking about screening at age 40.

For men unable to make a decision about screening after these conversations, the ACS recommends a doctor decide whether or not to screen based on knowledge of a patient's health preferences and values. After a decision to screen is made, the new guidelines make the digital rectal exam portion of the testing optional, and they say it is acceptable to extend the period between screenings for men with low PSA levels.

Partridge says there are limits to both PSA and the digital-exam method, and even when these tests detect cancer, physicians often can't tell how dangerous the cancer is without further tests or medical procedures. Some prostate cancers grow slowly and never cause any problems; others may grow aggressively.

Physicians and cancer-prevention experts note the urgent need for better ways to detect and treat early-stage prostate cancer, particularly the need to distinguish between cancers that do not require treatment and those that are actively growing. The American Urological Association, for example, insists that shared decision-making should involve personal data that is more in-depth than age, such as ethnicity, family history, previous biopsy characteristics and other factors.

Until new screening tools are available, it is crucial for care providers and cancer-prevention program directors give men the opportunity to decide whether they wish to pursue early detection for this disease.


Contact: Troy Goodman
University of Alabama at Birmingham

Related medicine news :

1. Certain Bone Drugs May Lower Breast Cancer Risk
2. New Prostate Cancer Guidelines Aim to Empower the Patient
3. Pre-Diagnosis Diet Linked to Ovarian Cancer Survival
4. Acupuncture may relieve joint pain caused by some breast cancer treatments
5. Henry Ford Hospital study shows link between vitamin D, skin cancer
6. Physicians come together on National Colorectal Cancer Awareness and Screening Day
7. A new indicator of poor prognosis in node-negative colorectal cancer patients
8. Vaccine for Asbestos-Related Cancer Looks Safe
9. WebMD Health Foundation Honored as Leader in Health by CancerCare
10. A critical moment in the field of lung cancer
11. Radiation Most Effective Soon After Breast Cancer Surgery
Post Your Comments:
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
Breaking Medicine Technology: